Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Berico

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanomaLuca Di Leo, Chiara Pagliuca, Ali Kishk, et al.
Cell Reports|November 4, 2023
Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stabilityPietro Berico, Maguelone Nogaret, Max Cigrang, et al.
Nature Communications|January 8, 2025
Pan-inhibition of super-enhancer-driven oncogenic transcription by next-generation synthetic ecteinascidins yields potent anti-cancer activityMax Cigrang, Julian Obid, Maguelone Nogaret, et al.
Cancer Discovery|February 3, 2026
A targetable developmental program co-regulates angiogenesis and immune evasion in melanomaPietro Berico, Amanda Flores Yanke, Fatemeh Vand-Rajabpour, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Chromatin architecture and physical constriction cooperate in phenotype switching and cancer cell disseminationPietro Berico, Cody Dunton, Luay Almassalha, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanomaLuca Di Leo, Chiara Pagliuca, Ali Kishk, et al.
Cell Reports|November 4, 2023
Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stabilityPietro Berico, Maguelone Nogaret, Max Cigrang, et al.
Nature Communications|January 8, 2025
Pan-inhibition of super-enhancer-driven oncogenic transcription by next-generation synthetic ecteinascidins yields potent anti-cancer activityMax Cigrang, Julian Obid, Maguelone Nogaret, et al.
Cancer Discovery|February 3, 2026
A targetable developmental program co-regulates angiogenesis and immune evasion in melanomaPietro Berico, Amanda Flores Yanke, Fatemeh Vand-Rajabpour, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Chromatin architecture and physical constriction cooperate in phenotype switching and cancer cell disseminationPietro Berico, Cody Dunton, Luay Almassalha, et al.
Pageof 2